TD SYNNEX posted an upbeat Q2 with revenue of $19.58 billion, up 31% YoY, and EPS ahead of estimates. Management guided Q3 above consensus, with non-GAAP EPS guidance of $4.25-4.75 and revenue of $18.2-19.0 billion, while analysts raised price targets on the stock. Despite the beat, the stock fell about 2.4% on Friday, suggesting near-term profit-taking or volatility, but the fundamentals and raised targets point to potential upside in the coming quarters.
TD Synnex is forecasted to report earnings of $3.31 per share, up from $2.80 last year. With an expected revenue increase to $15.65 billion and a consistent dividend yield, investor sentiment may remain positive leading into the earnings release.
SNX reported Q4 revenue of $17.4 billion, exceeding expectations. Adjusted EPS of $3.83 surpassed forecasts by 0.10 per share. CEO noted strengths in their specialized business model and customer experience. Analysts made changes to price targets following the earnings announcement. Shares rose 0.5%, trading at $148.32 post-results.
TD SYNNEX posted Q4 revenue of $17.4 billion, exceeding expectations. Adjusted EPS rose 24% YoY to $3.83, surpassing forecasts. Operating cash flow increased to $1.5 billion from $562 million last year. Dividend raised by 9.1% to 48 cents per share, payable January 2026. Projected Q1 EPS of $3.00-$3.50, above consensus of $3.21.
TD SYNNEX announces earnings on Jan. 8, 2025, expecting $0.94 EPS. Revenue estimates are $1.99 billion, up from last year's $1.96 billion. Morgan Stanley maintains Overweight rating, lowers price target to $177. Current dividend yield is 1.15%, with a payout of 44 cents quarterly. Stock has fallen 0.2% to close at $153.14 recently.
TD SYNNEX reported Q3 revenue of $15.65 billion, exceeding expectations. The company saw a 25.2% increase in adjusted earnings per share. Q4 revenue forecast is between $16.50 billion and $17.30 billion, higher than expected. Multiple analysts raised their price targets for TD SYNNEX post-earnings. TD SYNNEX shares gained 1% to $161.30 following the positive report.
